IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Boxer Capital, LLC

Q1 2020 Holdings

Filed 2020-05-15 | 62 holdings | $291.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Revolution Medicines Inc(RVMD)COM76155X100$66.8K3,049,7640.0%
Odonate Therapeutics IncCOM676079106$92.9K3,363,3770.0%
Immunomedics Inc(IMMU)COM452907108$113.9K8,450,0000.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$135.7K1,765,5600.0%
Axsome Therapeutics Inc(AXSM)COM05464T104$8.8M150,0003.0%
Cabaletta BIO Inc(CABA)COM12674W109$11.4M1,566,3613.9%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$15.6M370,0005.4%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$21.1M250,0007.2%
Argenx SE(ARGX)SPONSORED ADR04016X101$26.3M200,0009.0%
Arcus Biosciences Inc(RCUS)COM03969F109$42.8M3,084,88314.7%
Black Diamond Therapeutics I(BDTX)COM09203E105$50.3M2,014,85817.2%
Beigene LTD(ONC)SPONSORED ADR07725L102$113.9M925,00039.1%
PreviousPage 2 of 2